HEALTHCARE RESOURCE UTILIZATION AMONG COMMERCIALLY INSURED COLD AGGLUTININ DISEASE PATIENTS IN THE UNITED STATES

被引：0
|
作者：
Su, J. [1 ]
Bylsma, L. C. [2 ]
Jiang, X. [3 ]
Arias, Morales J. [1 ]
Jain, N. [1 ]
Nordyke, R. [4 ]
机构：
[1] Sanofi, Cambridge, MA USA
[2] EpidStrategies, Ann Arbor, MI USA
[3] EpidStrategies, Ann Arbor, MA USA
[4] 3Beta6 Consulting Grp, Los Angeles, CA USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.1703
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRO70
引用
收藏
页码：S348 / S348
页数：1
相关论文
共 50 条
  • [1] Healthcare resource utilization among commercially insured patients with cold agglutinin disease in the United States
    Su, Jun
    Bylsma, Lauren C.
    Jiang, Xiaohui
    Morales Arias, Jaime
    Jain, Nisha
    Nordyke, Robert J.
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (08) : 902 - 907
  • [2] Healthcare resource utilization among patients with cold agglutinin disease in Denmark
    Vago, Emese K.
    Nicholson, Gina
    Horvath-Puho, Erzsebet
    Hooda, Naushin
    Fryzek, Jon P.
    Su, Jun
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (10) : 1829 - 1835
  • [3] HEALTHCARE RESOURCE UTILIZATION AND COSTS AMONG COMMERCIALLY INSURED PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA) IN THE UNITED STATES
    Bonafede, M. M.
    McMorrow, D.
    Marshall, A.
    Gupta, K.
    Pazirandeh, M.
    [J]. VALUE IN HEALTH, 2018, 21 : S125 - S125
  • [4] Seasonal Patterns of Anemia, Hemolytic Markers and Healthcare Resource Utilization Among Patients Cold Agglutinin Disease in the United States: A Retrospective Analysis
    Roeth, Alexander
    Fryzek, Jon
    Jiang, Xiaohui
    Morales, Jaime
    Broome, Catherine M.
    [J]. BLOOD, 2018, 132
  • [5] HEALTHCARE RESOURCE UTILIZATION (HRU) AMONG PATIENTS WITH COLD AGGLUTININ DISEASE (CAD) IN DENMARK
    Vago, E. K.
    Nicholson, G.
    Horvath-Puho, E.
    Fryzek, J. P.
    Su, J.
    [J]. VALUE IN HEALTH, 2020, 23 : S697 - S697
  • [6] The Epidemiology, Clinical Outcomes, and Healthcare Resource Utilization of IgG4-Related Disease Among Commercially Insured People in the United States
    Wallace, Zachary
    Miles, Gandarvaka
    Smolkina, Ekaterina
    Petruski-Ivleva, Natalia
    Madziva, Duane
    Cook, Claire
    Fu, Xiaoqing
    Zhang, Yuqing
    Stone, John
    Choi, Hyon
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1425 - 1428
  • [7] HEALTHCARE COST AND UTILIZATION OF HEPATIC ENCEPHALOPATHY: ANALYSIS OF COMMERCIALLY INSURED PATIENTS IN THE UNITED STATES
    Elsaid, Mohamed I.
    Li, You
    John, Tina
    Pentakota, Ram
    Rustgi, Vinod K.
    [J]. HEPATOLOGY, 2019, 70 : 261A - 261A
  • [8] Patterns of treatment and healthcare resource utilization among commercially insured patients with diabetic neuropathy
    Zhao, Yang
    Bao, Yanjun
    Boulanger, Luke
    Ye, Wenyu
    Boye, Kristina S.
    Russell, Mason
    [J]. DIABETES, 2008, 57 : A228 - A228
  • [9] BURDEN OF ILLNESS, ANNUAL HEALTHCARE UTILIZATION, AND COSTS ASSOCIATED WITH COMMERCIALLY INSURED PATIENTS WITH CUSHING DISEASE IN THE UNITED STATES
    Broder, Michael S.
    Neary, Maureen P.
    Chang, Eunice
    Cherepanov, Dasha
    Ludlam, William H.
    [J]. ENDOCRINE PRACTICE, 2015, 21 (01) : 77 - 86
  • [10] Cost and resource utilization associated with glioblastoma among commercially insured adults in the United States (US).
    Jiang, Shan
    Hill, Kala
    Patel, Dipen
    Waldeck, Adrian Reg
    Botteman, Marc
    Norden, Andrew David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345